Person: Panetsos Petrova, Fivos
Loading...
First Name
Fivos
Last Name
Panetsos Petrova
Affiliation
Universidad Complutense de Madrid
Faculty / Institute
Óptica y Optometría
Department
Biodiversidad, Ecología y Evolución
Area
Matemática Aplicada
Identifiers
2 results
Search Results
Now showing 1 - 2 of 2
Item Biomaterials to Neuroprotect the Stroke Brain: A Large Opportunity for Narrow Time Windows(Cells, 2020) González Nieto, Daniel; Fernández Serra, Rocío; Pérez Rigueiro, José; Panetsos Petrova, Fivos; Martinez Murillo, Ricardo; Guinea, Gustavo V.Ischemic stroke represents one of the most prevalent pathologies in humans and is a leading cause of death and disability. Anti-thrombolytic therapy with tissue plasminogen activator (t-PA) and surgical thrombectomy are the primary treatments to recanalize occluded vessels and normalize the blood flow in ischemic and peri-ischemic regions. A large majority of stroke patients are refractory to treatment or are not eligible due to the narrow time window of therapeutic efficacy. In recent decades, we have significantly increased our knowledge of the molecular and cellular mechanisms that inexorably lead to progressive damage in infarcted and peri-lesional brain areas. As a result, promising neuroprotective targets have been identified and exploited in several stroke models. However, these considerable advances have been unsuccessful in clinical contexts. This lack of clinical translatability and the emerging use of biomaterials in different biomedical disciplines have contributed to developing a new class of biomaterial-based systems for the better control of drug delivery in cerebral disorders. These systems are based on specific polymer formulations structured in nanoparticles and hydrogels that can be administered through different routes and, in general, bring the concentrations of drugs to therapeutic levels for prolonged times. In this review, we first provide the general context of the molecular and cellular mechanisms impaired by cerebral ischemia, highlighting the role of excitotoxicity, inflammation, oxidative stress, and depolarization waves as the main pathways and targets to promote neuroprotection avoiding neuronal dysfunction. In the second part, we discuss the versatile role played by distinct biomaterials and formats to support the sustained administration of particular compounds to neuroprotect the cerebral tissue at risk of damage.Item Resistance to Degradation of Silk Fibroin Hydrogels Exposed to Neuroinflammatory Environments(Polymers, 2023) Yonesi, Mahdi; Ramos, Milagros; Ramírez Castillejo, Carmen; Fernández Serra, Rocío; González Nieto, Daniel; Panetsos Petrova, Fivos; Belarra, Adrián; Chevalier, Margarita; Rojo, Francisco J.; Pérez Rigueiro, José; Guinea, Gustavo V.Central nervous system (CNS) diseases represent an extreme burden with significant social and economic costs. A common link in most brain pathologies is the appearance of inflammatory components that can jeopardize the stability of the implanted biomaterials and the effectiveness of therapies. Different silk fibroin scaffolds have been used in applications related to CNS disorders. Although some studies have analyzed the degradability of silk fibroin in non-cerebral tissues (almost exclusively upon non-inflammatory conditions), the stability of silk hydrogel scaffolds in the inflammatory nervous system has not been studied in depth. In this study, the stability of silk fibroin hydrogels exposed to different neuroinflammatory contexts has been explored using an in vitro microglial cell culture and two in vivo pathological models of cerebral stroke and Alzheimer’s disease. This biomaterial was relatively stable and did not show signs of extensive degradation across time after implantation and during two weeks of in vivo analysis. This finding contrasted with the rapid degradation observed under the same in vivo conditions for other natural materials such as collagen. Our results support the suitability of silk fibroin hydrogels for intracerebral applications and highlight the potentiality of this vehicle for the release of molecules and cells for acute and chronic treatments in cerebral pathologies. © 2023 by the authors.